Private Trust Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3K | Sell |
90
-62
| -41% | -$7.79K | ﹤0.01% | 1773 |
|
|
2025
Q1 | $16.8K | Buy |
152
+17
| +13% | +$1.88K | ﹤0.01% | 1629 |
|
|
2024
Q4 | $18.4K | Sell |
135
-1
| -0.7% | -$137 | ﹤0.01% | 1513 |
|
|
2024
Q3 | $15.7K | Buy |
136
+91
| +202% | +$10.5K | ﹤0.01% | 1566 |
|
|
2024
Q2 | $6.2K | Hold |
45
| – | – | ﹤0.01% | 1851 |
|
|
2024
Q1 | $6.21K | Sell |
45
-5
| -10% | -$690 | ﹤0.01% | 1829 |
|
|
2023
Q4 | $6.59K | Buy |
+50
| New | +$6.59K | ﹤0.01% | 1815 |
|
|
2023
Q2 | – | Sell |
-70
| Closed | -$7.09K | – | 2349 |
|
|
2023
Q1 | $7.09K | Sell |
70
-2
| -3% | -$202 | ﹤0.01% | 1716 |
|
|
2022
Q4 | $9K | Buy |
72
+11
| +18% | +$1.38K | ﹤0.01% | 1595 |
|
|
2022
Q3 | $6K | Buy |
+61
| New | +$6K | ﹤0.01% | 1625 |
|
|
2014
Q4 | – | Sell |
-631
| Closed | -$10K | – | 862 |
|
|
2014
Q3 | $10K | Hold |
631
| – | – | ﹤0.01% | 1113 |
|
|
2014
Q2 | $9K | Hold |
631
| – | – | ﹤0.01% | 1129 |
|
|
2014
Q1 | $10K | Buy |
+631
| New | +$10K | ﹤0.01% | 979 |
|